Literature DB >> 18059978

Potentiation of Excitotoxicity in HIV-1 Associated Dementia and the Significance of Glutaminase.

Nathan B Erdmann1, Nick P Whitney, Jialin Zheng.   

Abstract

HIV-1 Associated Dementia (HAD) is a significant consequence of HIV infection. Although multiple inflammatory factors contribute to this chronic, progressive dementia, excitotoxic damage appears to be an underlying mechanism in the neurodegenerative process. Excitotoxicity is a cumulative effect of multiple processes occurring in the CNS during HAD. The overstimulation of glutamate receptors, an increased vulnerability of neurons, and disrupted astrocyte support each potentiate excitotoxic damage to neurons. Recent evidence suggests that poorly controlled generation of glutamate by phosphate-activated glutaminase may contribute to the neurotoxic state typical of HAD as well as other neurodegenerative disorders. Glutaminase converts glutamine, a widely available substrate throughout the CNS to glutamate. Inflammatory conditions may precipitate unregulated activity of glutaminase, a potentially important mechanism in HAD pathogenesis.

Entities:  

Year:  2006        PMID: 18059978      PMCID: PMC1832112          DOI: 10.1016/j.cnr.2006.09.009

Source DB:  PubMed          Journal:  Clin Neurosci Res        ISSN: 1566-2772


  194 in total

1.  Postembedding immunogold labelling reveals subcellular localization and pathway-specific enrichment of phosphate activated glutaminase in rat cerebellum.

Authors:  J H Laake; Y Takumi; J Eidet; I A Torgner; B Roberg; E Kvamme; O P Ottersen
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

2.  Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate.

Authors:  J W Olney
Journal:  Science       Date:  1969-05-09       Impact factor: 47.728

3.  Clinical pharmacology of CNS 1102 in man.

Authors:  K W Muir; D G Grosset; K R Lees
Journal:  Ann N Y Acad Sci       Date:  1995-09-15       Impact factor: 5.691

Review 4.  Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome.

Authors:  S A Lipton; H E Gendelman
Journal:  N Engl J Med       Date:  1995-04-06       Impact factor: 91.245

5.  Regional changes in amino acid content in developing rat brain.

Authors:  R W Cutler; D S Dudzinski
Journal:  J Neurochem       Date:  1974-11       Impact factor: 5.372

6.  Domoic acid neurotoxicity in cultured cerebellar granule neurons is mediated predominantly by NMDA receptors that are activated as a consequence of excitatory amino acid release.

Authors:  F W Berman; T F Murray
Journal:  J Neurochem       Date:  1997-08       Impact factor: 5.372

7.  Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry.

Authors:  O Bagasra; E Lavi; L Bobroski; K Khalili; J P Pestaner; R Tawadros; R J Pomerantz
Journal:  AIDS       Date:  1996-06       Impact factor: 4.177

8.  Complexity and species variation of the kidney-type glutaminase gene.

Authors:  L David Porter; Hend Ibrahim; Lynn Taylor; Norman P Curthoys
Journal:  Physiol Genomics       Date:  2002-04-16       Impact factor: 3.107

9.  Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors.

Authors:  Angela M Floden; Shanshan Li; Colin K Combs
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

10.  In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system.

Authors:  G J Nuovo; F Gallery; P MacConnell; A Braun
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

View more
  26 in total

Review 1.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

2.  Glutaminase dysregulation in HIV-1-infected human microglia mediates neurotoxicity: relevant to HIV-1-associated neurocognitive disorders.

Authors:  Yunlong Huang; Lixia Zhao; Beibei Jia; Li Wu; Yuju Li; Norman Curthoys; Jialin C Zheng
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

Review 3.  A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.

Authors:  Stephanie D Kraft-Terry; Shilpa J Buch; Howard S Fox; Howard E Gendelman
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

4.  Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection.

Authors:  Andrew C Young; Constantin T Yiannoutsos; Manu Hegde; Evelyn Lee; Julia Peterson; Rudy Walter; Richard W Price; Dieter J Meyerhoff; Serena Spudich
Journal:  Neurology       Date:  2014-09-26       Impact factor: 9.910

5.  Glutaminase C overexpression in the brain induces learning deficits, synaptic dysfunctions, and neuroinflammation in mice.

Authors:  Yi Wang; Yuju Li; Runze Zhao; Beiqing Wu; Blaise Lanoha; Zenghan Tong; Justin Peer; Jianhui Liu; Huangui Xiong; Yunlong Huang; Jialin Zheng
Journal:  Brain Behav Immun       Date:  2017-06-15       Impact factor: 7.217

6.  Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders.

Authors:  Michael T Nedelcovych; Boe-Hyun Kim; Xiaolei Zhu; Lyndah E Lovell; Arena A Manning; Jennifer Kelschenbach; Eran Hadas; Wei Chao; Eva Prchalová; Ranjeet P Dash; Ying Wu; Jesse Alt; Ajit G Thomas; Rana Rais; Atsushi Kamiya; David J Volsky; Barbara S Slusher
Journal:  J Neuroimmune Pharmacol       Date:  2019-06-17       Impact factor: 4.147

Review 7.  Glutamate metabolism and HIV-associated neurocognitive disorders.

Authors:  Fabián J Vázquez-Santiago; Richard J Noel; James T Porter; Vanessa Rivera-Amill
Journal:  J Neurovirol       Date:  2014-05-28       Impact factor: 2.643

Review 8.  Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders.

Authors:  James Keblesh; Dehui Hu; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2008-05-06       Impact factor: 4.147

9.  Expression of ephrin receptors and ligands in postmortem brains of HIV-infected subjects with and without cognitive impairment.

Authors:  Vadim Yuferov; Ann Ho; Susan Morgello; Yaning Yang; Jurg Ott; Mary Jeanne Kreek
Journal:  J Neuroimmune Pharmacol       Date:  2013-01-12       Impact factor: 4.147

10.  Glutamate production by HIV-1 infected human macrophage is blocked by the inhibition of glutaminase.

Authors:  Nathan Erdmann; Jianxing Zhao; Alicia L Lopez; Shelley Herek; Norman Curthoys; Terry D Hexum; Takashi Tsukamoto; Dana Ferraris; Jialin Zheng
Journal:  J Neurochem       Date:  2007-07       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.